
Please contact the doctor's office to verify that your insurance is accepted.
Pinkal Desai MD, MPH is an Associate Professor of Medicine at Weill Cornell Medical College and Attending Physician at the New York-Presbyterian Hospital.
After obtaining her MBBS at Byramjeejeebhoy Medical College in India in 2005, Dr. Desai obtained an MPH at the University of Alabama at Birmingham School of Public Health. Following her residency at Wayne State University, Detroit Medical Center, she underwent fellowship training in Hematology-Medical Oncology at Providence Hospital Medical Center, serving as Chief Fellow from 2012-2013. Dr. Desai was recruited to serve in our Leukemia Program to develop a clinical practice devoted to leukemia, myelodysplastic syndrome (MDS) and...
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study.
A nested case-control study of monoclonal gammopathy of undetermined significance in the Multiethnic Cohort study.